HCC patients were categorized into four groups: hPG80−/AFP− (n = 42), hPG80−/AFP+ (n = 21), hPG80+/AFP− (n = 54) and hPG80+/AFP+ (n = 48) (Table 1). This evidence concerns the gene AFP and hepatocellular carcinoma.